Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

October 13, 2023

Study Completion Date

October 13, 2023

Conditions
Radiotherapy, Conformal (IMRT)Head and Neck CancerOtolaryngologySurgeonsRadiation Oncologists
Interventions
OTHER

Systematic consideration of the advice of the ENT surgeon in the determination of the radiotherapy target volumes in head and neck cancers.

The contouring of the different target volumes will be first performed by the radiotherapists. During the Head and Neck Tumor Board, the volumes initially determined by the radiotherapists will be analyzed jointly by the radiotherapists and the patient's ENT surgeon to carry out, if necessary, modifications, taking into account clinical observations, intraoperative findings (if any) and endoscopy findings. Concordance parameters will be calculated in a second time with the determined volumes (in particular, index of concordance, coefficient of similarity).

Trial Locations (2)

75019

Fondation Ophtalmologique A. de Rothschild, Paris

92140

Hôpital d'Instruction des Armées, Clamart

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03265873 - Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers | Biotech Hunter | Biotech Hunter